Clinical Trial Update: A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 study results for trastuzumab (Herceptin) in combination therapy for metastatic urothelial cancer have been reported; the trial is completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Urinary Tract Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-02-11